摘要:
Four halogen-substituted analogues of N-methylepibatidine, a nicotinic acetylcholine receptor (nAChR) ligand, were synthesized. They were (+)-exo-N-methyl-2-(2-halogeno-5-pyridyl)-7- azabicyclo[2.2.1]heptanes, where halogeno = F (1a), Cl (2a), Br (3a), I (4a). (+/-)-N-Ethylepibatidine (2b) also was synthesized. The compounds 1a, 2a, 3a, and 4a and their corresponding normethyl analogues 1, 2, 3, and 4 inhibited the in vitro binding of [H-3]epibatidine to nAChRs to a similar degree, with affinities in the 27-50 pM range. The binding affinity of N-ethylepibatidine (2b), however, was substantially lower. The N-[C-11]methyl derivatives of 1, 2, and 3 were synthesized from high-specific radioactivity [C-11]methyl iodide using a high-temperature/high-pressure technique. The corresponding radiolabeled compounds [C-11]1a, [C-11]2a, and [C-11]3a were administrated to mice intravenously. The pattern of regional distribution of the three tracers in the mouse brain following intravenous administration matched those of [H-3]epibatidine, [H-3]norchloroepibatidine, and (+/-)-exo-2-(2-[F-18]fluoro-5-pyridyl)-7-azabicyclo[2.2.1]heptane ([F-18]FPH), which are highly specific nAChR probes. The initial brain uptake of the C-11 analogues and the acute toxicity of the corresponding authentic nonlabeled compounds appeared to be related to their lipophilicity.